Cargando…

GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?

Mood disorders are associated with significant psychosocial and occupational disability. It is estimated that major depressive disorder (MDD) will become the second leading cause of disability worldwide by 2020. Existing pharmacological and psychological treatments are limited for targeting cognitiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inkster, Becky, Zai, Gwyneth, Lewis, Gemma, Miskowiak, Kamilla W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181907/ https://www.ncbi.nlm.nih.gov/pubmed/30310078 http://dx.doi.org/10.1038/s41398-018-0270-z

Ejemplares similares

Neural and Behavioral Predictors of Treatment Efficacy on Mood Symptoms and Cognition in Mood Disorders: A Systematic Review
por: Seeberg, Ida, et al.
Publicado: (2018)

Whole-Brain Exploratory Analysis of Functional Task Response Following Erythropoietin Treatment in Mood Disorders: A Supervised Machine Learning Approach
por: Nielsen, Søren F. V., et al.
Publicado: (2019)

Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial
por: Petersen, Jeff Zarp, et al.
Publicado: (2018)

Dehydration Influences Mood and Cognition: A Plausible Hypothesis?
por: Benton, David
Publicado: (2011)

The Effect of Recombinant Erythropoietin on Plasma Brain Derived Neurotrophic Factor Levels in Patients with Affective Disorders: A Randomised Controlled Study
por: Vinberg, Maj, et al.
Publicado: (2015)

Erythropoietin as candidate for supportive treatment of severe COVID-19
por: Ehrenreich, Hannelore, et al.
Publicado: (2020)

“Trace” the Element: The Plausible Role Played by Selenium in the Erythropoietin Hyporesponsiveness
por: Azancot, Sarah, et al.
Publicado: (2022)

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder
por: Miskowiak, Kamilla W, et al.
Publicado: (2010)

Does Cognitive Dysfunction in Bipolar Disorder Qualify as a Diagnostic Intermediate Phenotype?—A Perspective Paper
por: Kessing, Lars Vedel, et al.
Publicado: (2018)

Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial
por: Schmidt, Lejla Sjanic, et al.
Publicado: (2018)

Erythropoietin promotes hippocampal mitochondrial function and enhances cognition in mice
por: Jacobs, Robert A., et al.
Publicado: (2021)

Hippocampal Subfield Volumes in Mood Disorders
por: Cao, Bo, et al.
Publicado: (2017)

Social cognition and bipolar disorder: pending questions and unexplored topics
por: de Siqueira Rotenberg, Luisa, et al.
Publicado: (2022)

Erythropoietin Protects Against Cognitive Impairment and Hippocampal Neurodegeneration in Diabetic Mice
por: Othman, Manal A. M., et al.
Publicado: (2018)

Effects of Short-Term Cognitive Remediation on Cognitive Dysfunction in Partially or Fully Remitted Individuals with Bipolar Disorder: Results of a Randomised Controlled Trial
por: Demant, Kirsa M., et al.
Publicado: (2015)

Cognition in mood disorders
por: Douglas, Katie M., et al.
Publicado: (2020)

Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses
por: Bortolato, Beatrice, et al.
Publicado: (2015)

The role of GSK-3 in mood disorders: Preliminary data from an experimental study
por: Salvo, G. Di, et al.
Publicado: (2021)

The BDNF Val66Met Polymorphism Has No Effect on Encoding-Related Hippocampal Response But Influences Recall in Remitted Patients With Bipolar Disorder
por: Hørlyck, Lone Diana, et al.
Publicado: (2019)

Evaluating endophenotypes for bipolar disorder
por: Guglielmo, Riccardo, et al.
Publicado: (2021)

Effects of cognitive remediation on cognitive dysfunction in partially or fully remitted patients with bipolar disorder: study protocol for a randomized controlled trial
por: Demant, Kirsa M, et al.
Publicado: (2013)

Local and regional heterogeneity underlying hippocampal modulation of cognition and mood
por: Tannenholz, Lindsay, et al.
Publicado: (2014)

Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues
por: Begemann, Martin, et al.
Publicado: (2021)

Association between childhood trauma, cognition, and psychosocial function in a large sample of partially or fully remitted patients with bipolar disorder and healthy participants
por: Miskowiak, Kamilla Woznica, et al.
Publicado: (2023)

Editorial: Cognition in Mood Disorders
por: Oyesanya, Mayowa, et al.
Publicado: (2020)

Neurocognitive processing of infant stimuli in mothers and non-mothers: psychophysiological, cognitive and neuroimaging evidence
por: Bjertrup, Anne, et al.
Publicado: (2021)

An ethnographic study of the effects of cognitive symptoms in patients with major depressive disorder: the IMPACT study
por: Ebert, Bjarke, et al.
Publicado: (2017)

Unlocking mechanisms in interleukin-1β-induced changes in hippocampal neurogenesis—a role for GSK-3β and TLX
por: Green, H F, et al.
Publicado: (2012)

Erythropoietin enhances hippocampal long-term potentiation and memory
por: Adamcio, Bartosz, et al.
Publicado: (2008)

Erythropoietin affects GABAergic transmission in hippocampal neurons in vitro
por: Wójtowicz, Tomasz, et al.
Publicado: (2008)

Comparison of Neurite Outgrowth Induced by Erythropoietin (EPO) and Carbamylated Erythropoietin (CEPO) in Hippocampal Neural Progenitor Cells
por: Oh, Dong Hoon, et al.
Publicado: (2012)

Proceedings from the Digital Innovation in Mental Health Conference, London, 2017
por: Inkster, Becky
Publicado: (2018)

Early Warning Signs of a Mental Health Tsunami: A Coordinated Response to Gather Initial Data Insights From Multiple Digital Services Providers
por: Inkster, Becky
Publicado: (2021)

Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial
por: Ott, Caroline V., et al.
Publicado: (2018)

Correction to: Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial
por: Ott, Caroline V., et al.
Publicado: (2019)

Dynamic range of GSK3α not GSK3β is essential for bidirectional synaptic plasticity at hippocampal CA3-CA1 synapses
por: Shahab, Lion, et al.
Publicado: (2014)

Cognitive plausibility in voice-based AI health counselors
por: Kannampallil, Thomas, et al.
Publicado: (2020)

GSK-3β activation accelerates early-stage consumption of Hippocampal Neurogenesis in senescent mice
por: Liu, Fei, et al.
Publicado: (2020)

Stress, glucocorticoid hormones, and hippocampal neural progenitor cells: implications to mood disorders
por: Kino, Tomoshige
Publicado: (2015)

Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin
por: Wakhloo, Debia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iqs5o2bcqe7v7u8ipng6c66mca